EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors

Guangfeng Wang, Dana C Borcherding, Jiawan Wang, Xiaochun Zhang, Liuzhan Yang, Gorkem Oztosun, James J Sears, Kangwen Xiao, Belinda B Garana, Mark I Zoberi, Aaron U Bektas, Jeffrey J Szymanski und 6 weitere

Journal of Clinical Investigation · 2026

DOI: 10.1172/jci201331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Guangfeng Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine, Washington University in St. Louis School of Medicine and Siteman Cancer Center, St. Louis, Missouri, U…. Hauptthemen laut MEDLINE: Focal Adhesion Kinase 1, Chromosomes, Human, Pair 8, Protein Kinase Inhibitors, Nerve Sheath Neoplasms. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, CDMRP NFRP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aneuploidy is a hallmark of cancer often associated with inferior prognosis. Copy number gains of chromosome 8 (chr8) are recurrent in multiple cancers, including breast, prostate, and colorectal cancers, and sarcomas, such as malignant peripheral nerve sheath tumors (MPNSTs). MPNSTs are aggressive, hard-to-treat sarcomas frequently linked to the neurofibromatosis type 1 (NF1) cancer predisposition syndrome. To investigate the role of chr8 gain in MPNST pathogenesis, we performed a CRISPR-knockout screen and identified 58 essential genes on chr8, including PTK2 , which encodes focal adhesion kinase (FAK). We evaluated FAK as a therapeutic target and tested small-molecule FAK inhibitors (FAKi) alone or combined with RAF/MEK inhibitors (RAF/MEKi), a class of agents relevant to NF1-deficient tumors with ERK pathway hyperactivation. Both pharmacological and genetic inhibition of FAK reduced MPNST cell proliferation in vitro and tumor growth in vivo. Combined FAKi and RAF/MEKi treatment further suppressed phosphorylation of FAK, STAT3, and AKT while increasing cleaved caspase-3 and poly (ADP-ribose) polymerase 1 (PARP-1), indicating enhanced apoptosis. In MPNST patient-derived xenograft (PDX) models, combination therapy significantly reduced tumor growth, showing superior efficacy, particularly in chr8 gain MPNST PDX. These results support FAK/RAF/MEK cotargeting as a promising therapeutic strategy for chr8 gain MPNST and related tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Focal Adhesion Kinase 1Chromosomes, Human, Pair 8Protein Kinase InhibitorsNerve Sheath NeoplasmsNeoplasm ProteinsNeurofibrosarcomaHumansAnimalsMiceCell Line, TumorFemale

Stichwörter der Autor:innen

BiomarkersCancerCell biologyDrug therapyOncology

Substanzen

Focal Adhesion Kinase 1PTK2 protein, humanProtein Kinase InhibitorsNeoplasm Proteins

Autor:innen und Institutionen

  • Division of Oncology, Department of Medicine, Washington University in St. Louis School of Medicine and Siteman Cancer Center, St. Louis, Missouri, USA.
  • Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Biological Sciences, Pacific Northwest National Laboratory, Seattle, Washington, USA.
  • Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Verastem Oncology, Needham, Massachusetts, USA.
  • Department of Biomedical Engineering, Oregon Health and Sciences University, Portland, Oregon, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • CDMRP NFRP
  • St. Louis Men’s Group Against Cancer
  • The Neurofibromatosis Therapeutic Acceleration Program
  • NINDS
  • NCI Cancer Center
  • Battelle Memorial Institute

Zitieren

APA

Wang, G., Borcherding, D. C., Wang, J., Zhang, X., Yang, L., Oztosun, G., Sears, J. J., Xiao, K., Garana, B. B., Zoberi, M. I., Bektas, A. U., Szymanski, J. J., Rathore, R., Coma, S., Pachter, J. A., Gosline, S. J., Pratilas, C. A., & Hirbe, A. C. (2026). Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors. Journal of Clinical Investigation. https://doi.org/10.1172/jci201331

Vancouver

Wang G, Borcherding DC, Wang J, Zhang X, Yang L, Oztosun G, et al. Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors. Journal of Clinical Investigation. 2026. doi:10.1172/jci201331

BibTeX
@article{Wang2026,
  author = {Wang, Guangfeng and Borcherding, Dana C and Wang, Jiawan and Zhang, Xiaochun and Yang, Liuzhan and Oztosun, Gorkem and Sears, James J and Xiao, Kangwen and Garana, Belinda B and Zoberi, Mark I and Bektas, Aaron U and Szymanski, Jeffrey J and Rathore, Richa and Coma, Silvia and Pachter, Jonathan A and Gosline, Sara Jc and Pratilas, Christine A and Hirbe, Angela C},
  title = {Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors},
  journal = {Journal of Clinical Investigation},
  year = {2026},
  doi = {10.1172/jci201331}
}
Kostenlos starten →